Track Amrutanjan Health Care Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 0.53 %
Low
493.0
High
516.0
1 Month returns: -4.21 %
Low
482.6
High
550.5
1 Year returns: -34.43 %
Low
482.6
High
784.8
3 Year CAGR: -8.09 %
Low
482.6
High
862.6
5 Year CAGR: -6.98 %
Low
482.6
High
1,024.6
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Amrutanjan Health Care Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Amrutanjan Health Care Ltd. Shareholding Pattern
Quarterly breakdown of Amrutanjan Health Care Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Amrutanjan Health Care Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Amrutanjan Health Care Ltd.?
The current share price of Amrutanjan Health Care Ltd. is ₹ 501.00 as of 8 Sep 2026.
What is the market capitalisation of Amrutanjan Health Care Ltd.?
The market capitalisation of Amrutanjan Health Care Ltd. stands at ₹ 1,447.79 Cr.
What is the PE ratio of Amrutanjan Health Care Ltd.?
The Price-to-Earnings (PE) ratio of Amrutanjan Health Care Ltd. is 26.82 as of the latest trailing twelve months data.
What is the ROE and ROCE of Amrutanjan Health Care Ltd.?
Amrutanjan Health Care Ltd. has a Return on Equity (ROE) of 16.62% and a Return on Capital Employed (ROCE) of 19.80% as per the latest financial reports.
What is the 52-week high and low of Amrutanjan Health Care Ltd.?
The 52-week high of Amrutanjan Health Care Ltd. is - and the 52-week low is -.
What is the dividend yield of Amrutanjan Health Care Ltd.?
The dividend yield of Amrutanjan Health Care Ltd. is 0.98% based on the current market price.
What is the FII and DII holding in Amrutanjan Health Care Ltd.?
Foreign Institutional Investors (FII) hold 2.44%, Domestic Institutional Investors (DII) hold 5.91% and retail/public investors hold 37.16% of Amrutanjan Health Care Ltd. shares.
What sector does Amrutanjan Health Care Ltd. belong to?
Amrutanjan Health Care Ltd. operates in the Healthcare sector.
What is the beta of Amrutanjan Health Care Ltd.?
The beta of Amrutanjan Health Care Ltd. is 0.46, indicating its price volatility relative to the broader market. Over the past 1 year, Amrutanjan Health Care Ltd. has delivered an absolute return of -31.34%.
What is the RSI of Amrutanjan Health Care Ltd.?
The 14-day Relative Strength Index (RSI) of Amrutanjan Health Care Ltd. is 44.01, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Amrutanjan Health Care Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
High and stable ROE
The company reported strong ROE of 16.62% for 12-month ended 30 Jun 2026 and ROE improved marginally by 9 bps from 1 year ago
What is ROE (FY)?
Moderate operating margin but improving trend
The company reported moderate operating margin of 13.8% for 12-month ended 30 Jun 2026 but operating margin improved by 154 bps from 1 year ago
What is Operating profit margin?
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.0 as on 30 Jun 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year
What is Debt to Equity?
Consistently pays dividend
The company has not missed dividend payments once in the last 10 financial years
What is Dividend streak?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Weak price momentum
Price Momentum score of 17.8 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term
What is Price Momentum score?
17.8 / 100
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of -1.03% for 12-month ended 30 Jun 2026 and the growth was 8.23 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Low dividend yield
The company has a low dividend yield of 0.98%
What is Dividend yield?
Neutral
Stock appears expensive but is at a discount to industry median P/E
PE TTM of 26.82 indicates that the stock is expensive on a standalone basis but discount to industry median P/E is decent at -15.61%
What is P/E Ratio?
Median: 31.78
Value 26.82
-0.96721.13
Moderate revenue growth and in line with median growth of industry
The company delivered moderate revenue growth of 10.68% for 12-month ended 30 Jun 2026 and the growth was 0.09 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 10.59
Value 10.68
-99.6111701.8
Company's earnings are of moderate quality
Earnings quality score of 51.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
51.0 / 100
No red flags found!
No significant red flags found in the stock.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Promoter
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.04
50.04
50.59
50.59
50.59
50.59
46.52
46.52
46.52
46.52
46.52
46.52
46.52
46.52
Indian Promoter
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.02
50.04
50.04
50.59
50.59
50.59
50.59
46.52
46.52
46.52
46.52
46.52
46.52
46.52
46.52
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
12.81
11.60
9.88
9.37
9.76
9.00
8.47
7.97
7.57
7.58
7.17
7.15
7.86
7.92
7.85
8.04
8.67
8.87
12.94
13.42
13.71
15.11
15.28
15.27
14.83
14.72
Mutual Funds / UTI
5.21
5.21
5.24
5.28
7.34
7.08
6.73
5.93
5.93
5.94
6.06
6.14
6.92
6.93
6.79
6.79
6.79
6.76
9.21
9.21
7.55
7.55
7.55
7.55
7.02
5.82
FI/Bank/Insurance
0.17
0.21
0.11
0.11
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
4.69
3.63
2.36
1.95
2.00
1.50
1.53
1.83
1.43
1.42
0.87
0.76
0.68
0.69
0.75
0.80
1.38
1.55
2.34
2.30
2.30
2.41
2.38
2.27
2.17
2.44
Other Institutions
2.74
2.55
2.17
2.03
0.33
0.33
0.12
0.12
0.12
0.13
0.15
0.16
0.17
0.20
0.22
0.36
0.41
0.47
1.30
1.83
3.77
5.06
5.26
5.36
5.55
6.38
Non-Institution
37.17
38.38
40.10
40.60
40.22
40.98
41.51
42.01
42.41
42.39
42.81
42.83
42.11
42.05
41.57
41.37
40.74
40.54
40.54
40.06
39.77
38.37
38.20
38.22
38.65
38.76
Bodies Corporate
2.55
2.31
2.07
2.38
2.49
2.33
2.15
2.18
-
2.23
2.11
2.12
2.05
1.97
1.82
1.84
1.75
1.72
1.81
1.69
1.56
1.52
1.63
1.74
1.71
1.60
Others (incl. Retail)
No. of shareholders
34.62
20,961
36.07
26,864
38.03
30,576
38.22
29,978
37.73
29,200
38.65
33,439
39.36
41,336
39.83
61,040
42.41
67,281
40.16
65,809
40.70
70,705
40.71
71,738
40.06
69,593
40.08
71,061
39.75
71,664
39.53
68,072
38.99
62,372
38.82
56,905
38.73
54,251
38.37
53,565
38.21
51,389
36.85
49,148
36.57
47,668
36.48
46,397
36.94
45,540
37.16
44,913
Name
Month
Transaction
Holding % pre transaction
Average price
Qty.
Transaction value
S Jeyakanth
Designated Person
May-2025
Market Sale (Disposal)
29th May 2025
0.01 %
₹ 0.00
1.40 k
₹ 0.00
Nageswaramma Private Trust
Promoter
October-2024
Market Sale (Disposal)
3rd Oct 2024
5.92 %
₹ 726.66
3.40 lac
₹ 24.73 cr
Nageswaramma Private Trust
Promoter
September-2024
Market Sale (Disposal)
30th Sep 2024
8.80 %
₹ 741.08
8.33 lac
₹ 61.71 cr
NAGESWARAMMA PRIVATE TRUST
Promoter Group
May-2022
Inter-se Transfer (Acquisition)
17th May 2022
4.90 %
₹ 0.00
10.76 lac
₹ 0.00
Dr. PASUMARTHI SATHYANARAYANA MURTHI
Promoter Group
May-2022
Inter-se Transfer (Disposal)
17th May 2022
3.81 %
₹ 0.00
10.76 lac
₹ 0.00
PASUMARTHI SATHYANARAYANA MURTHI
Promoter & Director
March-2022
Inter-se Transfer (Disposal)
7th Mar 2022
8.71 %
₹ 0.00
14.32 lac
₹ 0.00
AMRUTANJAN HEALTH CARE LIMITED ESOP TRUST
Trust
February-2022
Market Purchase (Acquisition)
23rd Feb 2022
0.15 %
₹ 761.25
10.10 k
₹ 76.89 lac
AMRUTANJAN HEALTH CARE LIMITED ESOP TRUST
Trust
February-2022
Market Purchase (Acquisition)
18th Feb 2022
0.11 %
₹ 782.20
10.00 k
₹ 78.22 lac
AMRUTANJAN HEALTH CARE LIMITED ESOP TRUST
Trust
February-2022
Market Purchase (Acquisition)
18th Feb 2022
0.11 %
₹ 785.46
50.00
₹ 39.27 k
AMRUTANJAN HEALTH CARE LIMITED ESOP TRUST
Trust
February-2022
Market Purchase (Acquisition)
18th Feb 2022
0.15 %
₹ 790.40
50.00
₹ 39.52 k
…
Corporate Actions
History of Amrutanjan Health Care Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Dividend₹ 2.90/share
Record date: 11th Sep 2026Ex-date: 11th Sep 2026
Announced on: 8th May 2026
Dividend₹ 1/share
Record date: 7th Feb 2026Ex-date: 6th Feb 2026
Announced on: 3rd Feb 2026
Dividend₹ 1/share
Record date: 18th Nov 2025Ex-date: 18th Nov 2025
Announced on: 10th Nov 2025
Dividend₹ 2.60/share
Record date: 16th Sep 2025Ex-date: 16th Sep 2025
Announced on: 15th May 2025
Dividend₹ 1/share
Record date: 18th Feb 2025Ex-date: 18th Feb 2025
Announced on: 12th Feb 2025
Company Profile
Overview of Amrutanjan Health Care Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene and services in pain management. Its segments include OTC Products, Women Hygiene, Beverages and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Women Hygiene includes Comfy Snug Fit, Comfy Snug Fit Extra Long, and Comfy Snug Fit Ultra XL. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint.
Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene and services in pain management. Its segments include OTC Products, Women Hygiene, Beverages a...
Key personnel
Mr. N. Swaminathan
Chief Financial Officer
Mr. Mani Bhagavatheeswaran
Chief Marketing Officer
Mr. Gagan Preet Singh
General Manager - Legal, Company Secretary & Compliance Officer
Mr. S. Jeyakanth
Chief Operating Officer - Supply Chain and Product Delivery
Mr. Soumomoy Pal
Associate Vice President - Information Technology
Dr. J. Ravichandran
Associate Vice President - QC/ QA/ R&D
Mr. Sambhu Prasad SivalenkaD
Executive Chairman of the Board, Managing Director